Explore. Discover. Innovate.
Connecting the Rutgers Research Community                                            March 5, 2019
Jump to:
Search for STEM Experts at Rutgers:

Annual Report on Research Now Available

The latest annual report on research for fiscal year 2018 is now available online and in print.  Read more
Tell Us What You Think - Website Survey

A project is underway t o redesign several prominent university websites, including ORED's site. To be successful, we need your input. Please take a few minutes to complete a short survey to help us better understand how you use the website. Take the Survey
Financial Conflict of Interest: Disclosure of Foreign Financial Interests Required

All investigators working on research projects are required by to disclose financial information that may reasonably be perceived to influence their work. A web-based system called eCOI (electronic conflict of interest management) is used for these financial disclosures. This is a reminder that anyone using this system must disclose financial interests foreign sources Investigators may exclude financial interests that come from domestic institutions of higher education as defined in 20 U.S.C. 1001(a) when disclosing financial interests. These include U.S. institutions of higher education or federal, state, or local government agencies. However, investigators, including sub-recipient investigators, must disclose all financial interests received from a foreign institution of higher education or from the government of another country, including any local, provincial, or equivalent governments of another country.  For more information regarding investigator disclosures of foreign interests or if you need help using the eCOI system , contact Sefilat Ajishafe, Conflict of Interest Administrator in Research Regulatory Affairs.
Resources for Researchers
Regenerative Tissue and Defense-Related Medicine Research Consortia Provide Unique Funding Opportunities

Memberships in three research conso rtia provide Rutgers with unique funding opportunities in the biomedical field. The Advanced Regenerative  Manufacturing Institute ( ARMI ) is a self-sustaining program in the expanding regenerative medicine and manufacturing industry addressing public health needs.  The Medical CBRN Defense Consortium ( MCDC ) advances development efforts to support the Department of Defense's (DoD) medical pharmaceutical and diagnostic requirements as related to enhancing the mission effectiveness of military personnel.  The Medical Technology Enterprise Consortium ( MTEC ) accelerates the development of revolutionary biomedical solutions that will enhance wound healing and return America's military, veterans, and ultimately, civilians to fully functioning lives.  If you're interested in learning more about how these memberships can help advance your research, contact the Research Development team.
Funding Spotlight
Limited Submission Opportunities
The William T. Grant Scholars Program supports career development for promising early-career researchers. The program funds five-year research and mentoring plans that significantly expand researchers' expertise in new disciplines, methods, and content areas. Awards are based on applicants' potential to become influential researchers, as well as their plans to expand their expertise in new and significant ways. Major divisions (e.g., School of Arts and Sciences, Medical School) of an institution may nominate only one applicant each year and pre-proposals must be submitted through the Rutgers Limited Submission process   . The internal application deadline is April 17, 2019.

Alzheimer's Drug Discovery Foundation's Program Accelerate Clinical Trials 
The goal of the Program to Accelerate Clinical Trials is to increase the number of innovative pharmacologic interventions tested in clinical studies for Alzheimer's disease and related dementias. This RFP supports clinical trials, experimental medicine, and regulatory studies for novel drugs (small molecules and biologics including antibodies, peptides, gene therapies), repurposed drugs (existing drugs that are approved for other diseases and conditions), repositioned drugs (existing drugs that have entered clinical trials for other indications and have not yet been approved), and natural products. Letter of Intent Deadline: April 12, 2019

NSF Releases Quantum Leap Challenge Institutes (QLCI)
The National Science Foundation released a solicitation for its Quantum Leap Challenge Institutes program. These Institutes are large-scale interdisciplinary research projects that aim to advance the frontiers of quantum information science and engineering. Two types of awards will be supported under this program: 12-month Conceptualization Grants to support teams envisioning subsequent Institute proposals and five-year Challenge Institute awards to establish and operate Quantum Leap Challenge Institutes (QLCI). Letters of Intent for Conceptualization Grant proposals are due April 1, 2019. Letters of Intent for Round I of the QLCI are due June 3, 2019 with preliminary proposals due by August 1, 2019.

Grants & Awards
Congratulations...  to the following Rutgers researchers for their recently-awarded grants: 

Jean-Francois Daneault - School of Arts and Sciences
Carolyn K. Suzuki - New Jersey Medical School
Zhaohui Feng - Rutgers Cancer Institute of New Jersey
Benedetto Piccoli - Camden Faculty of Arts and Sciences
Kevin Tong - Human Genetic Institute of New Jersey 

Learn about their research under Grant Announcements .
Upcoming Events
March 20-21 - New Jersey Center for Biomaterials Symposium: "Emerging Challenges in Tissue Engineering & Regenerative Medicine for the Next 15 Years"

We Want to Hear From You!
  • Have any exciting research-related news or events you want to share with Rutgers faculty and more than 850 research staff members? 
  • Want to add someone to our mailing list?
  • Need help finding someone at ORED but don't know where to start? 
Send us a message at We'd love to hear from you! 
To view past issues of Research Connections , visit our  Archives

Copyright ©2018 , Rutgers University, an equal opportunity, affirmative action institution. 
Office of Research and Economic Development: